Skip to main content
. 2024 Mar 8;15:1274442. doi: 10.3389/fphar.2024.1274442

TABLE 8.

PRSschizophrenia2 values in responders and non-responders and logistic multivariate regression analysis between PRSschizophrenia and response to treatment.

N PRS mean ± SD (range) OR (95% CI) P Sensitivity (%) Specificity (%) PPV (%) NPV (%) Cutoff
Responders Non-Responders
All patients 460 −0.37 ± 0.61 (−2.14—1.21) −0.33 ± 0.55 (−1.65—1.05) 0.82 (0.59–1.14) 0.24 61 55 62 54 −3.5
SCZ, SA, BD 235 −0.34 ± 0.59 (−2.14/1.08) −0.31 ± 0.58 (−1.65/1.05) 1.04 (0.73–1.48) 0.82 60 57 63 54 −2.65
SCZ, SA 176 −0.36 ± 0.59 (−2.14/1.08) −0.30 ± 0.61 (−1.65/1.04) 0.88 (0.53–1.46) 0.62 66 62 67 61 −0.90
SCZ 149 −0.34 ± 0.61 (−2.14/1.08) −0.32 ± 0.57 (−1.54/1.05) 0.98 (0.55–1.70) 0.93 59 57 62 53 −3.01
SA 27 −0.41 ± 0.45 (−1.13/0.24) −0.24 ± 0.80 (−1.65/0.83) 0.80 (0.16–0.94) 0.78 67 93 89 78 −1.32
BD 59 −0.31 ± 0.59 (−1.64/0.52) −0.31 ± 0.46 (−1.23/0.56) 1.11 (0.35–1.00) 0.86 57 50 62 44 −0.010
Others 96 −0.36 ± 0.56 (−2.09/0.89) −0.33 ± 0.54 (−1.52/0.88) 0.61 (0.25–1.47) 0.27 68 71 70 70 −3.47

Results corrected for age, PC1, PC2, PC3, PC4, PC5. SCZ schizophrenia; SA, schizoaffective disorder; BD bipolar disorder; others include neurocognitive disorder, substance abuse disorder, depression, miscellaneous; N, number of patients; OR, odds ratio; 95% CI: 95 confidence interval; P, p-value; PC genetic principal components; PPV, positive predictive value; NPV, negative predictive value; cutoff, empirical optimal cut-off value to separate responders and non-responders, calculated according to the Youden’s method.